SELE and stroke disorder: Second, as described previously, immunomodulatory and anti-inflammatory cytokine release is targeted to activate blood vessels by the E-selectin antigen specificity of regulatory T cells, which are believed to be associated with brain tissue damage after stroke [29,30,31].